Tema Heart & Health ETF (HRTS)
NasdaqGM: HRTS
· Echtzeitkurs · USD
37.83
+0.50 (1.34%)
Zum Schluss: Aug 18, 2026, 3:25 PM
Tema Heart & Health ETF (HRTS) ETF Price, Holdings & Analysis
1.34% (1D)
| Geld | 26.28 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 54.27 Mio |
| NAV | 37.28 |
| Beta | k.A. |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | 25.72 |
| Ausstehende Anteile | k.A. |
| Auflagedatum | Nov 20, 2023 |
| Brief | 47.47 |
| Volumen | 3,549 |
| Ø Vol. (20D) | 5,819 |
| Eröffnung | 37.74 |
| Vortagesschluss | 37.33 |
| Tagesspanne | 37.70 - 37.86 |
| 52-Wk Range | 29.02 - 37.86 |
| Positionen | k.A. |
| Kostenquote | 0.75% |
Über HRTS
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.
Anlageklasse Equity
Tickersymbol HRTS
Auflagedatum Nov 20, 2023
Anbieter Tema Etfs
Website Fonds-Homepage
Börse NasdaqGM
Top 10 Positionen 48.89% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Eli Lilly And Co | LLY | 11.32% |
| Unitedhealth Group I... | UNH | 5.50% |
| Novo Nordisk As Clas... | NOVO-B.CO | 5.12% |
| Thermo Fisher Scient... | TMO | 4.54% |
| Roche Holding Ag Adr | RHHBY | 4.18% |
| Merck & Co Inc | MRK | 4.16% |
| Johnson & Johnson | JNJ | 3.86% |
| Astrazeneca PLC | AZN.L | 3.46% |
| Revolution Medicines... | RVMD | 3.44% |
| Novartis Ag Register... | NOVN.SW | 3.31% |
Dividenden Dividendenrendite 2.49%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Dec 10, 2025 | $0.4730 | k.A. |
| Dec 11, 2024 | $0.4690 | k.A. |
